TOMMASI, CHIARA
 Distribuzione geografica
Continente #
AS - Asia 1.125
NA - Nord America 1.080
EU - Europa 572
SA - Sud America 193
AF - Africa 92
Continente sconosciuto - Info sul continente non disponibili 43
OC - Oceania 2
Totale 3.107
Nazione #
US - Stati Uniti d'America 1.028
SG - Singapore 419
VN - Vietnam 243
CN - Cina 205
IT - Italia 157
BR - Brasile 142
HK - Hong Kong 96
IE - Irlanda 91
BD - Bangladesh 67
DE - Germania 65
ZA - Sudafrica 56
FR - Francia 49
SE - Svezia 44
NL - Olanda 35
GB - Regno Unito 24
AR - Argentina 22
CA - Canada 22
AT - Austria 19
ES - Italia 16
FI - Finlandia 16
IN - India 14
RU - Federazione Russa 13
MX - Messico 12
PL - Polonia 12
IQ - Iraq 11
JP - Giappone 11
PH - Filippine 9
CI - Costa d'Avorio 8
EC - Ecuador 8
PK - Pakistan 8
TR - Turchia 8
EG - Egitto 7
BE - Belgio 6
CO - Colombia 6
CZ - Repubblica Ceca 6
ID - Indonesia 5
MA - Marocco 5
TN - Tunisia 5
VE - Venezuela 5
PE - Perù 4
TW - Taiwan 4
UZ - Uzbekistan 4
CR - Costa Rica 3
DZ - Algeria 3
JM - Giamaica 3
MY - Malesia 3
NG - Nigeria 3
PA - Panama 3
PY - Paraguay 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
CL - Cile 2
DO - Repubblica Dominicana 2
GH - Ghana 2
HU - Ungheria 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
LV - Lettonia 2
PT - Portogallo 2
SA - Arabia Saudita 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CH - Svizzera 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
LY - Libia 1
MD - Moldavia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.065
Città #
Singapore 236
Ashburn 189
San Jose 127
Santa Clara 98
Hong Kong 92
Dublin 90
Ho Chi Minh City 72
Chandler 64
Beijing 61
Dallas 59
Hanoi 58
Council Bluffs 56
Johannesburg 51
Boardman 50
Shanghai 35
Los Angeles 28
New York 28
Parma 28
Munich 25
Lauterbourg 23
Hefei 19
Buffalo 18
Vienna 18
Frankfurt am Main 15
Milan 15
Haiphong 12
Bologna 11
São Paulo 11
Da Nang 10
Montreal 10
Phoenix 10
Tokyo 10
Abidjan 8
Nuremberg 8
Toronto 8
Turku 8
Princeton 7
Ravenna 7
Warsaw 7
Atlanta 6
Baghdad 6
Bremen 6
Des Moines 6
Rome 6
Seattle 6
Amsterdam 5
Brooklyn 5
Columbus 5
Denver 5
Düsseldorf 5
Ha Long 5
Helsinki 5
Marseille 5
Modena 5
Moscow 5
Reggio Emilia 5
Sassuolo 5
Stockholm 5
Ann Arbor 4
Belo Horizonte 4
Brasília 4
Brussels 4
Buenos Aires 4
Cascina 4
Charlotte 4
Manaus 4
Newark 4
Rio de Janeiro 4
Tashkent 4
Thái Nguyên 4
Verona 4
Wilmington 4
Barcelona 3
Bexley 3
Biên Hòa 3
Boston 3
Cape Town 3
City of London 3
Collecchio 3
Hyderabad 3
Istanbul 3
Jakarta 3
London 3
Madrid 3
Manchester 3
Olomouc 3
Orem 3
Pasadena 3
Providence 3
Querétaro 3
Quito 3
Santo André 3
Shenzhen 3
The Dalles 3
Thái Bình 3
Vũng Tàu 3
Woodbridge 3
Accra 2
Almaty 2
Ankara 2
Totale 1.920
Nome #
SARS-CoV-2 Infection Risk and COVID-19 Prevalence and Mortality in Cancer Patients During the First Wave of COVID-19 Pandemic in a Virus Epicenter in Northern Italy 188
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma 164
Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing 153
Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers 149
Synchronous and metachronous colorectal liver metastases: Impact of primary tumor location on patterns of recurrence and survival after hepatic resection 146
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016) 134
A review of immune checkpoint blockade in breast cancer 127
Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score 125
Nab-paclitaxel after docetaxel hypersensitivity reaction: case report and literature review 123
My best choice after a round trip from illness 120
Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer 117
A narrative review of the principal glucocorticoids employed in cancer 115
Nivolumab-Induced Guillain-Barré Syndrome Coupled With Remarkable Disease Response in a Case of Heavily Pretreated Lung Adenocarcinoma 109
Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents 108
Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm? 107
The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma 107
Hormone Receptor-Positive/HER2-Positive Breast Cancer: Hormone Therapy and Anti-HER2 Treatment: An Update on Treatment Strategies 103
The future potential of genome-wide mutational profiles in HRD detection in breast cancer 103
Bridging bench to bedside: The evolution and impact of translational research in oncology. The experience of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 101
Burnout and Oncology: an irreparable paradigm or a manageable condition? Prevention strategies to reduce Burnout in Oncology Health Care Professionals 97
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome? 95
Tissue Biomarkers in Gastric Cancer Treatment: Present and Future 83
Abscopal effect as part of treatment of oligometastatic head and neck cancer: A case report 83
The Innate Immune Microenvironment in Metastatic Breast Cancer 77
State of the art for metastatic pancreatic cancer treatment: Where are we now?* 77
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study 70
Noncoding RNAs emerging as novel biomarkers in pancreatic cancer 64
The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study 54
A telemedicine app for preventive medicine, genetic risk, cancer pharmacoprevention and follow up: a tool for cancer specialists and patients using smartphone, PC and tablet. Development of BreastApp 8
Totale 3.107
Categoria #
all - tutte 11.873
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.873


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202251 0 0 5 6 4 4 10 2 0 1 0 19
2022/2023276 27 21 18 14 37 29 3 14 91 2 15 5
2023/2024216 8 29 3 3 14 35 23 15 12 26 21 27
2024/2025707 36 29 43 34 59 73 30 38 77 79 55 154
2025/20261.730 148 153 194 152 217 96 153 68 242 146 90 71
2026/2027102 35 67 0 0 0 0 0 0 0 0 0 0
Totale 3.107